Who We Are
Endonovo Therapeutics is an early-stage biotechnology company developing non-invasive electromagnetic therapies for inflammatory, autoimmune and degenerative diseases. Our core technologies, Time-Varying Electromagnetic Fields (TVEMF), were originally developed at NASA to combat muscle and bone mass loss due to zero gravity environments.
Endonovo has forged a network of strategic alliances and collaborations with leading pharmaceutical and biotechnology companies around the world, as well as leading research and clinical institutions to develop and commercialize our platform and therapies.
Our Mission
Endonovo in its most basic form means to renew the inside. Our mission is to extend and enhance the human life by non-invasively regenerating tissues and organs that have become injured or damaged by disease and age.
Investors
Our Mission
“Endonovo” in its most basic form means to renew the inside.
Our mission is to extend and enhance the human life by non-invasively regenerating tissues and organs that have become injured or damaged by disease and age.
Our Mission
“Endonovo” in its most basic form means to renew the inside.
Our mission is to extend and enhance the human life by non-invasively regenerating tissues and organs that have become injured or damaged by disease and age.